To include your compound in the COVID-19 Resource Center, submit it here.

Cell Design Labs, Kite Pharma deal

Cell Design granted Kite exclusive, worldwide rights to develop and commercialize chimeric antigen receptor

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE